Zocto News
News

Waystar Considers Sale Amid Market Challenges, Sources Reveal

September 17, 2026
Waystar Considers Sale Amid Market Challenges, Sources Reveal
3 views
AI Summary

Waystar, a healthcare software firm, is exploring strategic options, including a potential sale, as its market valuation declines.

Waystar, a prominent provider of healthcare software solutions, is reportedly evaluating various strategic options, including a potential sale. This comes just two years after its public market debut in New York. According to seven individuals familiar with the situation, the company has engaged investment bank Evercore to assist in exploring these possibilities.

The Lehi, Utah-based company, which also operates out of Louisville, Kentucky, has seen its market value dip to approximately $4.8 billion. This decline follows a 24% decrease in its share price this year, reflecting broader challenges in the software sector. The potential sale could be a test of investor interest in software companies, which have faced increased scrutiny amid technological advancements such as artificial intelligence.

Strategic Shift and Market Positioning

Waystar has strategically positioned itself as a technology-driven company, focusing on automating and managing administrative tasks in healthcare. This approach was intended to secure higher valuations typically associated with tech firms, as opposed to healthcare service providers that rely more heavily on human resources.

Initially, this strategy found favor with investors, driving the stock price from $20 to a high of $45 in 2025. However, concerns over potential disruptions from AI advancements have since exerted downward pressure on the stock, as noted by Morgan Stanley analysts in a July report.

Ownership and Shareholder Insights

Formed through the 2017 merger of Zirmed and Navicure, Waystar was taken public in 2024 by major stakeholders including EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital. EQT remains the largest shareholder with a 13% stake, followed by CPPIB with 10% and BlackRock Institutional Trust Company holding 8%, according to LSEG data.

Representatives from EQT and BlackRock have declined to comment on the potential sale, while CPPIB did not immediately respond to inquiries. Evercore also did not respond to requests for comment. Meanwhile, Waystar has chosen not to comment on the matter.

Market Conditions and Future Prospects

The exploration of a sale or other strategic paths comes at a time when the software sector is experiencing volatility. The company's move could gauge whether there is renewed appetite among investors for software entities, despite concerns about technological disruption.

Waystar's situation highlights the challenges faced by companies attempting to balance innovation with market expectations in a rapidly evolving technological landscape. As the process remains in early stages, the outcome is uncertain, with sources cautioning that plans could change and a sale might not occur.

3 views